Intellia Therapeutics Inc (NTLA)
19.82
-1.35
(-6.38%)
USD |
NASDAQ |
Apr 25, 10:13
Intellia Therapeutics Total Assets (Quarterly): 1.301B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.301B |
| September 30, 2023 | 1.243B |
| June 30, 2023 | 1.323B |
| March 31, 2023 | 1.418B |
| December 31, 2022 | 1.520B |
| September 30, 2022 | 1.084B |
| June 30, 2022 | 1.110B |
| March 31, 2022 | 1.203B |
| December 31, 2021 | 1.294B |
| September 30, 2021 | 1.335B |
| June 30, 2021 | 672.24M |
| March 31, 2021 | 716.89M |
| December 31, 2020 | 676.32M |
| September 30, 2020 | 458.56M |
| June 30, 2020 | 490.83M |
| March 31, 2020 | 314.75M |
| December 31, 2019 | 334.28M |
| Date | Value |
|---|---|
| September 30, 2019 | 346.64M |
| June 30, 2019 | 352.44M |
| March 31, 2019 | 344.36M |
| December 31, 2018 | 347.32M |
| September 30, 2018 | 321.23M |
| June 30, 2018 | 339.78M |
| March 31, 2018 | 359.54M |
| December 31, 2017 | 376.24M |
| September 30, 2017 | 249.17M |
| June 30, 2017 | 264.98M |
| March 31, 2017 | 279.26M |
| December 31, 2016 | 298.97M |
| September 30, 2016 | 301.47M |
| June 30, 2016 | 310.62M |
| March 31, 2016 | 75.54M |
| December 31, 2015 | 82.14M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
314.75M
Minimum
Mar 2020
1.520B
Maximum
Dec 2022
905.03M
Average
1.084B
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
| Moderna Inc | 18.43B |
| Regeneron Pharmaceuticals Inc | 33.08B |
| NeuroMetrix Inc | 21.42M |
| Repligen Corp | 2.824B |
| Pacific Biosciences of California Inc | 1.746B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 250.81M |
| Shareholders Equity (Quarterly) | 1.050B |
| Current Ratio | 8.666 |